Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea

Acne Rosacea Clinical Trial

Official title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00041977
Study type	Interventional
Source	CollaGenex Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	June 2002

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03064438` - Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea	Phase 2
Active, not recruiting	`NCT05108025` - DMT310-005 Topical in the Treatment of Acne Rosacea	Phase 2
Completed	`NCT02147691` - Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study	Phase 4
Completed	`NCT02270411` - Inflammatory Cells From Various Pathologies
Recruiting	`NCT04214483` - A Pilot Study to Explore the Role of Gut Flora in Acne
Completed	`NCT03003104` - DMT210 Topical Gel in the Treatment of Acne Rosacea	Phase 2
Completed	`NCT00580723` - Effects of PRK 124 Lotion in Acne Rosacea	Phase 1/Phase 2
Completed	`NCT04555525` - A Pilot Study on the Use of Seysara for Rosacea	Phase 4